Chronic Gvhd Therapy

Towards personalized therapy for chronic GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Treatment Options for Chronic GvHD

Targeted Oncology

Advances in the prevention and treatment of GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Introduction to Chronic Graft versus Host Disease 2020

Chronic Graft versus Host Disease and the Gastrointestinal Tract 2016

Chronic Graft-vs-Host Disease (GVHD) of Skin and Connective Tissues 2018

Bringing ibrutinib to the frontline of chronic GvHD treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Introduction to Chronic Graft-versus-Host Disease 2019

Managing Chronic GVHD: 100 Days After Transplant and Beyond

Chronic Graft versus Host Disease of Skin and Connective Tissues 2016

Graft-versus-Host Disease: Advances in Prevention and Treatment

Overcoming the Challenges of Acute and Chronic GVHD

PeerView Oncology

Graft-Versus-Host Disease/Graft-Versus-Leukemia: Recent Advances in Therapy

Henry Ford Health

Graft-Versus-Host Disease by C. Duncan | OPENPediatrics

Updates in Chronic Graft-versus-Host Disease (GVHD) Management

International Academy for Clinical Hematology IACH

Management of chronic GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Introduction to Chronic Graft-vs-Host Disease (GVHD) 2018

GVHD - Assessing, Staging and Following Acute/Chronic Disease

Ruxolitinib and ibrutinib: the future for GvHD treatment?

VJHemOnc – Video Journal of Hematology & HemOnc

David Miklos, MD, PhD: Ibrutinib in Chronic Graft-Versus-Host Disease

American Society of Hematology